AKT1 and cancer: Consistent with the latter notion, FGF-2 treatment significantly enhanced cell proliferation of all the three cell lines (Fig. 1c) and also the activity of the pro-survival pathways PI3K-AKT in both normal and cancer cell lines (Fig. 1d).